ARD1A antibody
GTX125971
ApplicationsImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetNAA10
Overview
- SupplierGeneTex
- Product NameARD1A antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 1:500-1:10000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. IP: 1:100-1:500. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.73 mg/ml
- ConjugateUnconjugated
- Gene ID8260
- Target nameNAA10
- Target descriptionN-alpha-acetyltransferase 10, NatA catalytic subunit
- Target synonymsARD1, ARD1A, ARD1P, DXS707, LZMS, MAA, MCOPS1, NATD, OGDNS, TE2, hARD1, N-alpha-acetyltransferase 10, ARD1 homolog A, N-acetyltransferase, N-acetyltransferase ARD1, human homolog of, N-terminal acetyltransferase complex ARD1 subunit homolog A, arrest defective protein 1, microphthalmia or anophthalmia and associated anomalies, natA catalytic subunit Naa10
- HostRabbit
- IsotypeIgG
- Protein IDP41227
- Protein NameN-alpha-acetyltransferase 10
- Scientific DescriptionN-alpha-acetylation is one of the most common protein modifications that occurs during protein synthesis and involves the transfer of an acetyl group from acetyl-coenzyme A to the protein alpha-amino group. ARD1A, together with NATH (NARG1; MIM 608000), is part of a major N-alpha-acetyltransferase complex responsible for alpha-acetylation of proteins and peptides (Sanchez-Puig and Fersht, 2006 [PubMed 16823041]).[supplied by OMIM]
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Jiang Y, Guo X, Liu L, et al. Metagenomic characterization of lysine acetyltransferases in human cancer and their association with clinicopathologic features. Cancer Sci. 2020,111(5):1829-1839. doi: 10.1111/cas.14385Read this paper
- Takekoshi D, Tokuzawa Y, Sakanaka M, et al. The N-end rule pathway enzyme Naa10 supports epiblast specification in mouse embryonic stem cells by modulating FGF/MAPK. In Vitro Cell Dev Biol Anim. 2019,55(5):355-367. doi: 10.1007/s11626-019-00341-8Read this paper
- Owen J, McEwan C, Nesbitt H, et al. Reducing Tumour Hypoxia via Oral Administration of Oxygen Nanobubbles. PLoS One. 2016,11(12):e0168088. doi: 10.1371/journal.pone.0168088Read this paper




